Darunavir: A second-generation protease inhibitor

Pharmacology, Toxicology and Pharmaceutical Science

• Proteinase Inhibitor 100%
• Darunavir 100%
• HIV 31%
• Adverse Event 12%
• Drug-Drug Interaction 6%
• CYP3A4 6%
• Bioavailability 6%
• Proteinase 6%
• Cytochrome P450 6%
• Ritonavir 6%
• Drug Interaction 6%
• Tablet 6%
• Virus Strain 6%
• Liver Dysfunction 6%
• Plasma Protein 6%
• Virus RNA 6%
• Human Immunodeficiency Virus Proteinase 6%
• Mild Renal Impairment 6%
• Moderate Renal Impairment 6%
• Isoenzyme 6%
• Pharmacokinetics 6%

Keyphrases

• New Humanities 6%
• Human Immunodeficiency Virus-positive Patients 6%